Literature DB >> 23047477

Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study.

M Arora, J Pidala, C S Cutler, X Chai, B Kurland, D A Jacobsohn, S Z Pavletic, J Palmer, G Vogelsang, M Jagasia, K Schultz, S J Lee.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23047477      PMCID： PMC3942496          DOI： 10.1038/leu.2012.292

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

Authors:  Mukta Arora; John P Klein; Daniel J Weisdorf; Anna Hassebroek; Mary E D Flowers; Corey S Cutler; Alvaro Urbano-Ispizua; Joseph H Antin; Brian J Bolwell; Michael Boyiadzis; Jean-Yves Cahn; Mitchell S Cairo; Luis Isola; David A Jacobsohn; Madan Jagasia; Thomas R Klumpp; Stephanie J Lee; Effie W Petersdorf; Stella Santarone; Robert Peter Gale; Harry C Schouten; Stephen Spellman; John R Wingard; Mary M Horowitz; Steven Z Pavletic
Journal:  Blood       Date:  2011-04-14       Impact factor: 22.113

2.  Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study.

Authors:  Joseph Pidala; Georgia Vogelsang; Paul Martin; Xiaoyu Chai; Barry Storer; Steven Pavletic; Daniel J Weisdorf; Madan Jagasia; Corey Cutler; Jeanne Palmer; David Jacobsohn; Sally Arai; Stephanie J Lee
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

3.  Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.

Authors: 
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-19       Impact factor: 5.742

4.  Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

Authors:  Steven Z Pavletic; Paul Martin; Stephanie J Lee; Sandra Mitchell; David Jacobsohn; Edward W Cowen; Maria L Turner; Gorgun Akpek; Andrew Gilman; George McDonald; Mark Schubert; Ann Berger; Peter Bross; Jason W Chien; Daniel Couriel; J P Dunn; Jane Fall-Dickson; Ann Farrell; Mary E D Flowers; Hildegard Greinix; Steven Hirschfeld; Lynn Gerber; Stella Kim; Robert Knobler; Peter A Lachenbruch; Frederick W Miller; Barbara Mittleman; Esperanza Papadopoulos; Susan K Parsons; Donna Przepiorka; Michael Robinson; Michael Ward; Bryce Reeve; Lisa G Rider; Howard Shulman; Kirk R Schultz; Daniel Weisdorf; Georgia B Vogelsang
Journal:  Biol Blood Marrow Transplant       Date:  2006-03       Impact factor: 5.742

5.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

6.  Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.

Authors:  K M Sullivan; R P Witherspoon; R Storb; P Weiden; N Flournoy; S Dahlberg; H J Deeg; J E Sanders; K C Doney; F R Appelbaum
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

7.  Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

Authors:  Sally Arai; Madan Jagasia; Barry Storer; Xiaoyu Chai; Joseph Pidala; Corey Cutler; Mukta Arora; Daniel J Weisdorf; Mary E D Flowers; Paul J Martin; Jeanne Palmer; David Jacobsohn; Steven Z Pavletic; Georgia B Vogelsang; Stephanie J Lee
Journal:  Blood       Date:  2011-07-26       Impact factor: 22.113

8.  Chronic graft-versus-host disease: a prospective cohort study.

Authors:  Mukta Arora; Linda J Burns; Stella M Davies; Margaret L Macmillan; Todd E Defor; Wesley J Miller; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2003-01       Impact factor: 5.742

9.  Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

Authors:  Stephanie J Lee; John P Klein; A John Barrett; Olle Ringden; Joseph H Antin; Jean-Yves Cahn; Matthew H Carabasi; Robert Peter Gale; Sergio Giralt; Gregory A Hale; Osman Ilhan; Philip L McCarthy; Gerard Socie; Leo F Verdonck; Daniel J Weisdorf; Mary M Horowitz
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

10.  Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.

Authors:  Afonso C Vigorito; Paulo V Campregher; Barry E Storer; Paul A Carpenter; Carina K Moravec; Hans-Peter Kiem; Matthew L Fero; Edus H Warren; Stephanie J Lee; Frederick R Appelbaum; Paul J Martin; Mary E D Flowers
Journal:  Blood       Date:  2009-05-21       Impact factor: 22.113
View more
  4 in total

Review 1.  How we treat chronic graft-versus-host disease.

Authors:  Mary E D Flowers; Paul J Martin
Journal:  Blood       Date:  2014-11-14       Impact factor: 22.113

2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

3.  Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

Authors:  Mukta Arora; Michael T Hemmer; Kwang Woo Ahn; John P Klein; Corey S Cutler; Alvaro Urbano-Ispizua; Daniel R Couriel; Amin M Alousi; Robert Peter Gale; Yoshihiro Inamoto; Daniel J Weisdorf; Peigang Li; Joseph H Antin; Brian J Bolwell; Michael Boyiadzis; Jean-Yves Cahn; Mitchell S Cairo; Luis M Isola; David A Jacobsohn; Madan Jagasia; Thomas R Klumpp; Effie W Petersdorf; Stella Santarone; Harry C Schouten; John R Wingard; Stephen R Spellman; Steven Z Pavletic; Stephanie J Lee; Mary M Horowitz; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

4.  Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation.

Authors:  Gérard Socié; Marie Robin; Simona Pagliuca; Pedro Henrique Prata; Aliénor Xhaard; Camilla Frieri; Livia Giannoni; Aurelien Sutra Del Galy; Anne Brignier; Flore Sicre de Fontbrune; David Michonneau; Nathalie Dhedin; Régis Peffault de Latour
Journal:  Bone Marrow Transplant       Date:  2020-06-25       Impact factor: 5.483
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.